Trials / Completed
CompletedNCT00044772
Study Evaluating Venlafaxine ER in Patients With Panic Disorder
A Double-blind, Placebo-controlled, Parallel-group Comparison of Venlafaxine Extended-release Capsules and Paroxetine in Outpatients With Panic Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 653 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to determine the efficacy, safety, and tolerability of venlafaxine extended release (ER) capsules in the treatment of outpatients with panic disorder (PD) in comparison to those of placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Venlafaxine ER |
Timeline
- Start date
- 2001-11-01
- Primary completion
- 2003-04-01
- Completion
- 2003-04-01
- First posted
- 2002-09-06
- Last updated
- 2009-08-14
Source: ClinicalTrials.gov record NCT00044772. Inclusion in this directory is not an endorsement.